Clinical Trial Update: Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating afatinib as a therapy for exocrine pancreatic tumours. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: PD Dr. med. Volker Heinemann | Conditions: Focus of Study Instead | Phase 2 | Status: UNKNOWN